Matthias Fehr
Direktor/Vorstandsmitglied bei Swixx Biopharma SA
Profil
Matthias Fehr is currently the Director at Swixx Biopharma SA. He also holds the position of Head Private Equity at HBM Partners AG since 2020.
Previously, he worked as an Analyst at Lombard Odier Darier Hentsch & Cie (Equity Brokerage) in 2002.
Aktive Positionen von Matthias Fehr
| Unternehmen | Position | Beginn |
|---|---|---|
HBM Partners AG
 HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US. | Private Equity Investor | 01.08.2002 |
Swixx Biopharma SA
 Swixx Biopharma SA BiotechnologyHealth Technology Swixx Biopharma SA provides marketing and sales, regulatory, medical affairs, cold chain, logistic services to pharmaceutical companies. Its services also include receivables, collection, FX coverage, risk management, compliance, and reimbursement and market access. The company was founded by Petr Nemec and Robert Stuart Swanson in 2013 and is headquartered in Baar, Switzerland. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Matthias Fehr
| Unternehmen | Position | Ende |
|---|---|---|
| Lombard Odier Darier Hentsch & Cie (Equity Brokerage) | Analyst-Equity | 22.04.2002 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US. | Finance |
| Lombard Odier Darier Hentsch & Cie (Equity Brokerage) | Finance |
Swixx Biopharma SA
Swixx Biopharma SA BiotechnologyHealth Technology Swixx Biopharma SA provides marketing and sales, regulatory, medical affairs, cold chain, logistic services to pharmaceutical companies. Its services also include receivables, collection, FX coverage, risk management, compliance, and reimbursement and market access. The company was founded by Petr Nemec and Robert Stuart Swanson in 2013 and is headquartered in Baar, Switzerland. | Health Technology |
